CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer (Q44772343)
Jump to navigation
Jump to search
scientific article published in February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer |
scientific article published in February 2008 |
Statements
1 reference
CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer (English)
1 reference
Jonathan S Berek
1 reference
Peyton T Taylor
1 reference
Christopher F Nicodemus
1 reference
1 February 2008
1 reference
1 reference
Identifiers
1 reference